Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 1/14/2015
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||- / 2||UN / IM|
Administered by: Other Purchased by: Other
Symptoms: Abdominal pain, Asthenia, Headache, Muscular weakness, Viral infection, Wheelchair user, Walking aid user
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? Yes
Hospitalized? Yes, days: 61
Write-up:This spontaneous report as received from a consumer reporting on 10 year old daughter. On an unknown date the patient was vaccinated with a third dose of GARDASIL 0.5 ml, intramuscular (lot # not reported). On an unknown date the patient experienced headache, legs weakness, strength loss and abdominal pain initially diagnosed as a virus infection. However the patient presented a new relapse and was hospitalized for two months (dates unspecified). The patient was discharged on a wheelchair, without medical opinion. By the time of the report the patient must have used crutches in the daily routines. The patient did not recover from headache, legs weakness, strength loss and. The outcome of abdominal pain and viral infection was unknown. Relatedness between all events and GARDASIL was not specified. Upon internal review all events were assessed as disabling. Additional information is not expected as no follow up was available.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166